{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-038590","form_type":"8-K","ticker":"KAPA","cik":"0001962011","company_name":"Kairos Pharma, LTD.","filed_at":"2024-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.282971+00:00","generated_at":"2026-05-31T01:18:57.038042+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Kairos Pharma enters two service agreements: $615K cash + 50K RSUs","bullets":["CEO.CA Technologies to provide advertising and consulting for $250,000 over 12 months.","Belair Capital Advisors to provide strategic advisory for $365,000 plus 50,000 RSUs vesting in 6 months.","Services include digital marketing, market research, business development assistance, and stakeholder communication.","Both agreements are governed by Ontario law and contain standard indemnification clauses."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-038590","json":"https://secwatch.observer/filing/0001493152-24-038590.json","markdown":"https://secwatch.observer/filing/0001493152-24-038590.md","text":"https://secwatch.observer/filing/0001493152-24-038590.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1962011/000149315224038590/0001493152-24-038590-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1962011/000149315224038590/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T01:18:57.038042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}